Patent details
EP3391890 Title: POSACONAZOLE INTRAVENOUS SOLUTION FORMULATIONS STABILIZED BY SUBSTITUTED BETA-CYCLODEXTRIN
Basic Information
- Publication number:
- EP3391890
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- In force
- Application number:
- EP181716721
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- POSACONAZOLE INTRAVENOUS SOLUTION FORMULATIONS STABILIZED BY SUBSTITUTED BETA-CYCLODEXTRIN
- French Title of Invention:
- FORMULATIONS DE SOLUTION INTRAVEINEUSE DE POSACONAZOLE STABILISÉES PAR BÊTA-CYCLODEXTRINE SUBSTITUÉE
- German Title of Invention:
- DURCH SUBSTITUIERTES BETA-CYCLODEXTRIN STABILISIERTE INTRAVENÖSE POSACONAZOLLÖSUNGSFORMULIERUNGEN
- SPC Number:
Dates
- Filing date:
- 24/06/2011
- Grant date:
- 25/08/2021
- EP Publication Date:
- 24/10/2018
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 25/08/2021
- EP B1 Publication Date:
- 25/08/2021
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 24/06/2031
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 12/08/2022
- Name:
- Merck Sharp & Dohme LLC
- Address:
- 126 East Lincoln Avenue, Rahway, New Jersey 07065-0907, United States (US)
History of Owners
- From:
- 18/08/2021
- To:
- 12/08/2022
- Name:
- MERCK SHARP & DOHME CORP.
- Address:
- 126 East Lincoln Avenue, Rahway, NJ 07065-0907, United States (US)
Agent
- Name:
- MARKS & CLERK LLP
- From:
- 23/09/2021
- Address:
- BP 1775, 1017, LUXEMBOURG, Luxembourg (LU)
- To:
Inventor
1
- Name:
- Monteith, David
- Address:
- United States (US)
2
- Name:
- Heimbecher, Susan, K.
- Address:
- United States (US)
Priority
- Priority Number:
- 359701 P
- Priority Date:
- 29/06/2010
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 31/715; A61K 31/497; A61P 31/00; A61P 31/10; A61K 31/496; A61K 9/00; A61K 31/724; A61K 47/40; A61P 3/06; A61P 7/02; A61P 31/04; A61P 33/00; A61P 33/02; A61P 35/00; A61P 35/02; A61P 35/04; A61P 37/06; A61P 7/04; A61P 31/08; A61P 31/18;
Publication
European Patent Bulletin
1
- Issue number:
- 202134
- Publication date:
- 25/08/2021
- Description:
- Grant (B1)
2
- Issue number:
- 202226
- Publication date:
- 29/06/2022
- Description:
- Opposition procedure started
3
- Issue number:
- 202138
- Publication date:
- 22/09/2021
- Description:
- Application number/publication number of the divisional application (Art. 76) changed
4
- Issue number:
- 202237
- Publication date:
- 14/09/2022
- Description:
- Transfer of Rights
Annual Fees
- Annual Fee Due Date:
- 30/06/2025
- Annual Fee Number:
- 15
- Annual Fee Amount:
- 213 Euro
- Expected Payer:
- Last Annual Fee Payment Date:
- 14/05/2024
- Last Annual Fee Paid Number:
- 14
- Last Annual Fee Paid Amount:
- 198 Euro
- Payer:
- MASTER DATA CENTER INC (ex Clarivate Analytics)
| Filing date | Document type | Number of pages |
|---|---|---|
| 23/09/2021 | Power Of Attorney | 1 |
| 23/09/2021 | Outgoing Correspondence | 1 |
| 12/08/2022 | Request For Change | 1 |
| 02/09/2022 | Outgoing Correspondence | 56 |